Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05467449 · ClinicalTrials.gov registry record
DxFLEX 10C Clinical Study
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 527
- Enrollment target
NCT05467449: Completed study, sponsored by Beckman Coulter.
NCT05467449 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 527 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05467449 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 527 participants
- Enrollment target
Study Summary
A multi-center method comparison study is designed per CLSI-EP09 A3. This study compares the qualitative immunophenotype agreement between DxFLEX and Navios EX to demonstrate the accuracy of the DxFLEX-10C system. A series of precision studies will be conducted with each focusing on different aspects of the DxFLEX-10C system.
Primary Outcome
Based on WHO guidelines for Leukemia \& Lymphoma
Interventions
- DEVICE DxFLEX 10C
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 527 participants |
| Start Date | 2022-04-12 |
| Est. Completion | 2023-08-31 |
What the finished NCT05467449 record still lists
NCT05467449 is an observational study that tracks outcomes without assigning an intervention. The registered 527 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which DxFLEX 10C is the first listed.
NCT05467449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05467449 about?
NCT05467449 is a clinical study titled "DxFLEX 10C Clinical Study". A multi-center method comparison study is designed per CLSI-EP09 A3. This study compares the qualitative immunophenotype agreement between DxFLEX and Navios EX to demonstrate the accuracy of the DxFLEX-10C system. A series of precision studies will be conducted with each focusing on different aspect...
What is the current status of trial NCT05467449?
This trial is currently completed. The enrollment target is 527 participants. The study started on 2022-04-12. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05467449?
The interventions under investigation include: DxFLEX 10C (DEVICE).
Who is sponsoring clinical trial NCT05467449?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05373017 · 528 participants · NA
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
- NCT05634252 · 528 participants · Phase 3
Undergraduate Skin Cancer Prevention Trial
- NCT06383273 · 528 participants · Phase 3
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
- NCT06470243 · 528 participants · Phase 3
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI